Gilla Kaplan is a director of Avalo Therapeutics Inc.
Person profile
Roles
Avalo Therapeutics
Director
Tyra Biosciences
Director
Address
Summit, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Avalo Therapeutics, Inc.
21 Dec 23
4
Tyra Biosciences, Inc.
2 Jun 23
4
Avalo Therapeutics, Inc.
3 Oct 22
4
Avalo Therapeutics, Inc.
1 Jul 22
4
Tyra Biosciences, Inc.
15 Jun 22
4
Avalo Therapeutics, Inc.
15 Jun 22
4
Avalo Therapeutics, Inc.
4 Apr 22
4
Avalo Therapeutics, Inc.
4 Jan 22
4
Avalo Therapeutics, Inc.
4 Oct 21
3
Tyra Biosciences, Inc.
14 Sep 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Dec 23 | AVTX Avalo Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.043 | 3,334 | 143.36 | 3,334 |
31 May 23 | TYRA Tyra Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 14.47 | 14,500 | 209.82 k | 14,500 |